Arax Advisory Partners’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$96.6K Buy
3,814
+3,584
+1,558% +$81.5K ﹤0.01% 2755
2026
Q1
$1.88K Buy
230
+102
+80% +$2.12K ﹤0.01% 3122
2025
Q4
$2.74K Sell
128
-2,922
-96% -$59.9K ﹤0.01% 3140
2025
Q3
$51.1K Buy
3,050
+2,963
+3,406% +$44.4K ﹤0.01% 1825
2025
Q2
$1.25K Buy
+87
New +$1.19K ﹤0.01% 2713

Other funds holding MD

Arax Advisory Partners's MD Position: Q2 2026 in Review

Arax Advisory Partners increased its Pediatrix Medical (MD) stake by 1,558% in Q2 2026, buying an estimated $81.5K and bringing the position to 3,814 shares worth $96.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2755.

Arax Advisory Partners first reported a position in MD in Q2 2025 and has held it in 5 quarters since. 306 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Arax Advisory Partners held 3,814 shares of Pediatrix Medical worth $96.6K as of Q2 2026.
  • Arax Advisory Partners bought 3,584 Pediatrix Medical shares in Q2 2026, an estimated $81.5K.
  • Pediatrix Medical made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2755 holding.
  • Arax Advisory Partners first reported a position in Pediatrix Medical in Q2 2025 and has held it in 5 quarters since.
  • 306 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.